Baupharma
Baupharma is a Prague-based pharmaceutical professional services firm delivering pharmacovigilance, regulatory affairs, medical writing, batch release, translations, and clinical research support to pharmaceutical, biotech, vaccine, and supplements manufacturers across 120+ countries.
- Company typePrivate
- Founded2017
- HeadquartersPrague, Czechia
- Headcount51–100
- GTM typeB2B
- OfferingServices
What Baupharma does
Baupharma is a Prague-headquartered pharmaceutical professional services firm delivering regulatory affairs, pharmacovigilance, medical writing, batch release and distribution, translations, and clinical research support to pharmaceutical, biotechnology, vaccine, and supplements manufacturers globally. The firm positions itself as a one-stop-shop covering the full pharmaceutical product lifecycle — from clinical development and regulatory submissions through post-market safety surveillance and supply-chain release — for enterprise clients that lack the internal regulatory infrastructure to operate across multiple jurisdictions. Service delivery is organized around six integrated modules rather than a unified software platform, with pharmacovigilance (adverse event management, signal detection, aggregate reporting) and regulatory affairs (dossier preparation, submissions, lifecycle management) as the two anchor offerings.
Revenue is generated through bespoke professional services engagements with enterprise pharmaceutical clients, delivered via dedicated account teams under project-based and contractual arrangements; no public pricing or subscription offering exists. The firm operates through a direct enterprise sales motion, supported by four strategically placed regional offices and an extensive European affiliate and partner network that handles batch release, logistics, and distribution. The company has not raised external funding and is privately held, suggesting a bootstrapped, cash-generative operating model. Geographic reach spans 120+ countries across the EU, MENA, CIS, Africa, the Americas, and Asia-Pacific.
The team comprises approximately 51–100 employees per firmographics (with a stated bench of 100+ PV experts that likely includes contractors and affiliates), led by CEO Ahmed Diaa Eldin and supported by mid-level managers in PV project management and operations. Baupharma holds ISO 9001 certification from TÜV for quality management. The firm markets itself primarily through thought-leadership content (regulatory updates from FDA, EMA, MHRA) on its website blog and LinkedIn presence, with an RFI/RFP form for inbound enterprise inquiries. Note: the company claims 25+ years of experience while firmographics list a 2017 founding date — the 25+ years figure appears to refer to collective team/founder industry tenure rather than corporate history.
Baupharma firmographics
Firmographics- Name
- Baupharma
- Legal name
- Baupharma
- Website
- https://baupharma.com
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Baupharma is a Prague-based pharmaceutical professional services firm delivering pharmacovigilance, regulatory affairs, medical writing, batch release, translations, and clinical research support to pharmaceutical, biotech, vaccine, and supplements manufacturers across 120+ countries.
- Ownership category
- akta.pro rank
Baupharma industry classification
Industry- Product category
- Pharmaceutical Regulatory Services
- NAICS
- Other Scientific and Technical Consulting Services (54169)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Pharmacovigilance, Risk Management & Medical Affairs CROs (HLAGAAAH)
- akta.pro secondary industries
- Pharmacovigilance Quality & Compliance (PV audits, QPPV support, PSMF) (HLAGAKAH), Pharmacovigilance, Drug Safety & Risk Management FSP (HLAGAOAF)
Keywords
Where Baupharma is headquartered
LocationHeadquarters
- HQ city
- Prague
- HQ country
- Czechia
- HQ region
- Europe
Offices2 records
Markets served
Baupharma business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Revenue model
- Pharmacovigilance Services: Comprehensive drug safety monitoring services including adverse event management, signal detection, aggregate reporting, and risk management throughout the product lifecycle
- Regulatory Affairs Services: Regulatory strategy, dossier preparation, submissions, lifecycle management, and regulatory intelligence across global markets
- Medical Writing Services: Scientific and medical content creation for clinical documentation, regulatory submissions, and publications
- Batch Release & Distribution Services: Quality assurance, logistics, and distribution services for pharmaceutical supply chain management across Europe
- Clinical Research Services: Clinical development support, trial management, and regulatory coordination for clinical research projects
- Translation Services: Specialized pharmaceutical translation for clinical trial protocols, product labels, and regulatory documents
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
Baupharma product offering
Product offeringCore offering
Baupharma is a pharmaceutical service provider delivering six integrated service modules: pharmacovigilance (drug safety monitoring, adverse event management, signal detection, aggregate reporting), regulatory affairs (dossier preparation, submissions, lifecycle management, regulatory intelligence across global markets), medical writing (scientific and regulatory documentation), batch release and distribution (logistics, QA, supply chain support across Europe), translations (multilingual pharmaceutical technical documentation), and clinical research (clinical development and trial management). The company supports pharmaceutical, biotech, vaccine, and generic drug manufacturers across 120+ countries through a team of 100+ pharmacovigilance experts, with strategic offices in EU, MENA, CIS, USA, LATAM, and Asia-Pacific regions.
Product overview
Baupharma offers a comprehensive portfolio of six integrated pharmaceutical service modules. The core offering consists of Pharmacovigilance Services (drug safety monitoring and signal detection), Regulatory Affairs Services (global regulatory strategy and submissions), Medical Writing Services (scientific and regulatory documentation), Batch Release & Distribution Services (logistics and quality assurance across Europe), Translations Services (multilingual pharmaceutical documentation), and Clinical Research Services (clinical trial management and support). These services work together to provide end-to-end pharmaceutical lifecycle support, from drug development through post-market surveillance, with global reach across EU, MENA, CIS, Africa, USA, LATAM, and Asia-Pacific regions.
Differentiator
Problem solved
Functional benefit
Products and services
- Pharmacovigilance Services Comprehensive drug safety monitoring services ensuring safety and efficacy of medications throughout their lifecycle, including systematic data collection, assessment, analysis, adverse event management, signal detection, and aggregate reporting. Targeted at pharmaceutical companies requiring post-market safety surveillance.
- Regulatory Affairs Services Strategic guidance and support navigating regulatory compliance and product approval processes across global markets, including dossier preparation, submissions, lifecycle management, and regulatory intelligence. Targeted at pharmaceutical, biotech, vaccine, and generic drug manufacturers seeking market access across multiple jurisdictions.
- Medical Writing Services Crafting of accurate scientific and medical content combining scientific expertise with writing skills to deliver high-quality documentation for clinical, regulatory, and publication needs. Targeted at pharmaceutical sponsors requiring clinical and regulatory documentation.
- Batch Release & Distribution Services Comprehensive logistics, distribution, and quality assurance services delivered through an extensive network of affiliates and partners throughout Europe, handling all aspects of pharmaceutical supply chain including batch certification and product distribution. Targeted at pharmaceutical companies seeking European market access.
- Translations Services Professional translation services for critical pharmaceutical technical documentation including clinical trial protocols, product labels, and regulatory documents, supported by experienced translators and project managers. Targeted at pharmaceutical companies requiring multilingual documentation for global submissions.
- Clinical Research Services Clinical development and trial management activities supporting sponsors and research organisations through local expertise combined with a global perspective, addressing regulatory, logistical, and technical challenges across markets. Targeted at pharmaceutical sponsors and CRO partners.
Companies that use Baupharma
Customer profileNamed customers5 records
Segments4 records
Ideal customer profiles4 records
Baupharma technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Baupharma partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Extensive Network of Affiliates and Partners (Europe)coreBaupharma maintains an extensive network of affiliates and partners throughout Europe to efficiently handle all aspects of pharmaceutical supply chain including logistics, distribution, and quality assurance services. This network enables comprehensive batch release and distribution services across European markets.
Scale indicators5 records
Recent moves6 records
Expansion highlights6 records
Baupharma competitors and assessment
Company assessmentEmerging players
- iVigee: Specialized pharmacovigilance and regulatory services provider focused on EU and global markets. Smaller and emerging player in the same niche as Baupharma.
Direct peers
- Arriello: European-headquartered regulatory affairs and pharmacovigilance consulting firm supporting pharma and biotech clients. Strongly comparable specialty focus and client base to Baupharma.
- PrimeVigilance: Specialized pharmacovigilance and regulatory services CRO serving pharma and biotech clients globally. Highly comparable to Baupharma in core PV service line, multi-jurisdictional coverage, and mid-market positioning.
- Pharmalex: Regulatory affairs, pharmacovigilance, and quality management consulting firm serving pharma clients across multiple geographies. Strong overlap with Baupharma's regulatory and PV service modules.
- ProPharma Group: Provides regulatory affairs, pharmacovigilance, and compliance consulting for pharma and medical device companies. Directly comparable service portfolio and client base to Baupharma.
Broad incumbents
- ICON plc: Global CRO offering clinical, PV, regulatory, and laboratory services across the full drug development lifecycle. Overlaps with Baupharma's clinical research, PV, and regulatory offerings but at much larger scale.
- Parexel International: Large global CRO with regulatory, PV, and clinical research services. Comparable service mix to Baupharma, particularly in regulatory strategy and drug safety.
- Labcorp Drug Development (Fortrea): Large CRO spun out from Labcorp offering clinical, regulatory, and PV services. Competes with Baupharma for mid-to-large pharma contracts.
- Worldwide Clinical Trials: Mid-to-large CRO offering clinical research, PV, and regulatory services globally. Comparable multi-service positioning to Baupharma with broader scale.
- IQVIA: World's largest CRO with deep pharmacovigilance, regulatory affairs, and clinical research capabilities. Competes with Baupharma for enterprise pharma engagements, particularly in developed markets.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Baupharma social profiles
Digital presenceBaupharma compliance and trust
Trust signalCompliance1 record
Baupharma financial estimates
Financial estimateRevenue estimate
Valuation estimate
Baupharma leadership team
Management profileNumber of profiles
Profiles3 records
Baupharma funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Baupharma M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Baupharma
What does Baupharma do?
Baupharma is a pharmaceutical service provider delivering six integrated service modules: pharmacovigilance (drug safety monitoring, adverse event management, signal detection, aggregate reporting), regulatory affairs (dossier preparation, submissions, lifecycle management, regulatory intelligence across global markets), medical writing (scientific and regulatory documentation), batch release and distribution (logistics, QA, supply chain support across Europe), translations (multilingual pharmaceutical technical documentation), and clinical research (clinical development and trial management). The company supports pharmaceutical, biotech, vaccine, and generic drug manufacturers across 120+ countries through a team of 100+ pharmacovigilance experts, with strategic offices in EU, MENA, CIS, USA, LATAM, and Asia-Pacific regions.
Is Baupharma a public or private company?
Baupharma is a private company. It is classified as unknown and is currently operating.
When was Baupharma founded?
Baupharma was founded in 2017. It employs 51 to 100 people.
Where is Baupharma based?
Baupharma is headquartered in Prague, Czechia, in the Europe region.
How does Baupharma make money?
Six revenue lines are on record. Pharmacovigilance Services are the primary driver. The others are regulatory Affairs Services, medical Writing Services, batch Release & Distribution Services, clinical Research Services and translation Services.
Who are Baupharma's main competitors?
iVigee is listed as an emerging player. Direct peers are Arriello, PrimeVigilance, Pharmalex and ProPharma Group. Broad incumbents are ICON plc, Parexel International, Labcorp Drug Development (Fortrea), Worldwide Clinical Trials and IQVIA.
Does Baupharma have an API?
No public API is recorded for Baupharma.
What industry is Baupharma in?
Baupharma's product category is Pharmaceutical Regulatory Services. Its primary akta.pro industry code is HLAGAAAH, Pharmacovigilance, Risk Management & Medical Affairs CROs, with a secondary code of HLAGAKAH, Pharmacovigilance Quality & Compliance (PV audits, QPPV support, PSMF). Its NAICS code is 54169 and its SIC code is 8731.